In summary we show that blocking glucose uptake is synergistic with inhibition of SNAT2 demonstrating a balance between glycolysis and glutaminolysis in cancer cells that can be explored by a novel inhibitor of SNAT2. Here, SLC38A2 is linked to cancer.